2017 Annual Meeting

Vendor Supported Events


Vendor-supported symposia, which have been made possible through marketing support, will be offered on Thursday and Friday evening, as well as Saturday morning during the meeting. Details on these vendor-supported symposia is listed below and will be mailed to members and meeting registrants as soon as they are available.

NOTE: Vendor satellite symposia are supported by specific companies and are supported through a marketing grant. They are not part of the official program of the ASBrS and are free to all registered attendees.

THURSDAY EVENING SYMPOSIUM

Thursday, April 27
5:30 pm–7:30 pm

Genomic Health, Inc.
Grand Ballroom
This event will be held immediately following the Coding and Reimbursement Symposium in the same room. 

Genomic Assays and Patient Outcomes: Real-world Applications

Overall Program Objective: To offer perspectives on the analysis of outcomes data and their application in the choice of genomic assays for patients with early-stage breast cancer to enable informed treatment planning.

Description of Program: This program will feature a moderated panel discussion with 3-4 physician speakers presenting a range of patient cases and the implications of using genomic classifiers in the management of early-stage breast cancer. The program will also include a review and analysis of several key studies with outcomes data, eg TAILORx Trial, SEER and Clalit Breast Cancer Registry (Israel), and restaging using the 8th Edition of the AJCC Cancer Staging Manual. 

How to Register: Please click the following link to register: Genomic Health Symposium Registration.

NOTE: This satellite symposium is supported by Genomic Health, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


Friday evening Symposia

Friday, April 28
Satellite Symposia
7:30 pm–9:30 pm

Genentech, Inc. – Monet 1 and 2
Invuity, Inc. – Monet 3 and 4
Myriad Genetics, Inc. – Bellagio 6


Genentech, Inc.
Monet 1 and 2

Case-Based Preoperative Considerations in HER2+ Breast Cancer: A Multidisciplinary Approach

Program Overview: 
This program will discuss the use of PERJETA for the neoadjuvant treatment of HER2-positive early breast cancer by focusing on: case studies discussing appropriate patient selection for preoperative treatment, 2013 ASCO/CAP guidelines for HER2 testing, and clinical trial data on pathological complete response (pCR).

How to Register: You may RSVP by visiting www.GeneRSVP.com and entering PRF73351.

NOTE: This satellite symposium is supported by Genentech, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Friday Evening Symposia


Invuity, Inc.
Monet 3 and 4

Advanced Techniques, Considerations & Technologies in Hidden Scar™ Breast Cancer Surgery

Description of Program: This symposium will discuss the advanced techniques, considerations, and enabling technologies in Hidden Scar Breast Conserving Surgery and Hidden Scar Nipple Sparing Mastectomy that prioritize both the oncologic and psychosocial outcomes essential for breast cancer survivorship. Through each talk, the faculty will discuss how intracavity illumination enhanced energy and near infrared imaging technologies impact surgical experience and clinical outcomes

How to Register: Please register at info.invuity.com/2017ASBrSSymposium

NOTE: This satellite symposium is supported by Invuity, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Friday Evening Symposia


Myriad Genetics, Inc.
Bellagio 6

The Future of Breast Cancer Recurrence Testing – A Scientific Introduction to EndoPredict

Program Objectives:
Participants will gain an understanding of the clinical benefits of Myriad’s EndoPredict breast cancer recurrence test. During the symposium, participants will learn about the scientific development and clinical validation of EndoPredict, as well as clinical application of the EndoPredict test result. EndoPredict predicts early and late recurrence risk for patients with ER+, HER2- early stage breast cancer and up to 3 positive lymph nodes.

Description of Program:
EndoPredict is a breast cancer recurrence test for patients diagnosed with ER+, HER2- early stage breast cancer with up to 3 positive lymph nodes that was validated in over 4,000 patients. . This program will explore the data supporting the use of EndoPredict to assess the risk of distant metastases in years 0 to 10 post diagnosis when treated with 5 years of endocrine therapy. EndoPredict is a provided by Myriad Genetics Laboratories, a leader in molecular diagnostic testing.

How to Register: Please click the following link to register: The Future of Breast Cancer Recurrence Testing – A Scientific Introduction to EndoPredict RSVP

NOTE: This satellite symposium is supported by Myriad Genetics Laboratories, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


back to Friday Evening Symposia

 

Saturday Breakfast Symposia

Saturday, April 129
6:15 am–7:45 am

Programs:

top of page


 

Albert Einstein College of Medicine
Bellagio 3, 4, and 7


Virtual Cadaver Hand-On Workshop: Identifying Breast and Abdominal Planes for Surgical Infiltration to Manage Post-Surgical Pain

Overall Program Objectives:

  • Describe the opioid epidemic and associated adverse events with opioids.
  • Review the multimodal options utilized pre-op, inter-op and post-op in breast reconstruction surgery.
  • Identify the surgical anatomy targeting PECS I, II, III, serratus, classic tap, subcostal and rectus sheath blocks.
  • Adapt techniques via hands-on practice on live models and phantom stations.

Brief Description of Program:
The symposium will include a faculty presentation, questions and answers and a hands-on workshop. It will provide the learners with the opportunity to interact with faculty in real time.

How to Register: Please click the following link to register: www.eeds.com/live/860750. For more information, please contact Stacy Atkinson at statkins@montefiore.org or 718-920-6674.

Note: This satellite symposium is supported by Pacira Pharmaceuticals through an educational grant provided to Albert Einstein College of Medicine. CME credits for this program will be provided by Albert Einstein College of Medicine. It is not part of the official program of the ASBrS*. This activity is free to all registered attendees. (*An independent grant from Albert Einstein College of Medicine was provided to the ASBrS in order to offer this satellite symposium during the 18th Annual Meeting.)

back to Saturday Breakfast Symposia


BioTheranostics
Raphael 1 and 2

The Role of Genomics in Patient Selection for Extended Endocrine Therapy

Description:
Recent data on extended adjuvant endocrine therapy has emphasized the need for an individualized approach to identify candidates for prolonged treatment.  This presentation will put the recent data in the context of previous extended endocrine therapy trials and provide insight on how breast surgeons may apply the data in clinical practice by introducing a genomic assay that can help physicians with patient selection.

How To Register:  http://pages.breastcancerindex.com/bfst001/

NOTE: This satellite symposium is supported by BioTheranostics, through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Saturday Breakfast Symposia


Cianna Medical
DaVinci 1 and 2

Moving Beyond Wires:  A Non-Radioactive Solution to Breast Tumor Localization

Program Objectives: 
Breakfast meeting to learn more about the SAVI SCOUT, an FDA-Cleared surgical guidance system to provide real-time guidance during lumpectomies. 

How to Register:  To register, please visit https://www.regonline.com/builder/site/Default.aspx?EventID=1974467or scan this QR code

QR Code

NOTE: This satellite symposium is supported by Cianna Medical, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Saturday Breakfast Symposia


Dune Medical Devices and Carl Zeiss Meditec
Monet 1 and 2

Negative Margins in TARGiT IORT: Methods and techniques for achieving the most favorable result

Description: 
This program will discuss techniques for achieving negative margins when employing TARGiT Intraoperative Radiation Therapy for breast conserving surgery patients.  The program will combine presentation and panel discussion on two synergistic technologies: MarginProbe to overcome the challenges with margins in BCS; and TARGiT Intrabeam on proper patient selection, management, and follow-up of IORT patients.

Registration Link: https://www.regonline.com/ASBS2017

NOTE: This satellite symposium is supported by Dune Medical Devices, Inc. and Carl Zeiss Meditec through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Saturday Breakfast Symposia


Focal Therapeutics, Inc.
Bellagio 6


Improving Your Outcomes with Oncoplastic Surgery: Techniques in "Reconstructive Lumpectomy"

Brief Description of Program:
Topics will include principles and practice of oncoplastic breast conserving surgery with specific attention focused on "reconstructive lumpectomy".  Integration of the BioZorb implant will be covered including tips on patient selection, surgical techniques, and other "pearls" on how to optimize patient outcomes.  Impact on radiation therapy and coding for oncoplastic surgery will also be addressed.

HOW TO REGISTER:  Please RSVP to kmurray@focalrx.com.

NOTE: This satellite symposium is supported by Focal Therapeutics through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.

back to Saturday Breakfast Symposia


ImpediMed, Inc.
Monet 3 and 4

The Future of Survivorship

Program Objectives: 
An event discussing the changes in the field of Oncology and what is to come in the world of survivorship. Continuously striving to find ways to improve the patient’s quality of life.

Brief Summary and Description of Program: 
The battle of lymphedema begins with L-Dex. Find out how the technology of today could change the way we look at survivorship tomorrow. Come learn more about the future of survivorship and ways to continuously improve your patient's quality of life.

How to Register:  RSVP at: http://conta.cc/2mj8QeE

NOTE: This satellite symposium is supported by ImpediMed, Inc., through a marketing grant. It is not part of the official program of the ASBrS. This activity is free to all registered attendees.


back to Saturday Breakfast Symposia